Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

PHASE4CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
DiphtheriaTetanusPoliomyelitis
Interventions
BIOLOGICAL

Diphtheria, tetanus, polio and pertussis vaccination

1 dose of TETRAVAC-ACELLULAIRE (0.5 mL) at Day 0

Trial Locations (45)

Unknown

SPMSD Investigational Site 120, Angers

SPMSD Investigational Site 103, Arras

SPMSD Investigational Site 155, Asnières

SPMSD Investigational Site 125, Bersée

SPMSD Investigational Site 121, Besançon

SPMSD Investigational Site 141, Besançon

SPMSD Investigational Site 124, Blois

SPMSD Investigational Site 161, Blois

SPMSD Investigational Site 194, Boulogne-Billancourt

SPMSD Investigational Site 148, Brest

SPMSD Investigational Site 117, Caen

SPMSD Investigational Site 147, Caen

SPMSD Investigational Site 163, Champdeniers

SPMSD Investigational Site 135, Châlons-en-Champagne

SPMSD Investigational Site 145, Chigny-les-Roses

SPMSD Investigational Site 157, Cholet

SPMSD Investigational Site 101, Clamart

SPMSD Investigational Site 160, Collombey Les Belles

SPMSD Investigational Site 162, Collombey Les Belles

SPMSD Investigational Site 139, Dax

SPMSD Investigational Site 193, Draguignan

SPMSD Investigational Site 106, Essey-lès-Nancy

SPMSD Investigational Site 123, Essey-lès-Nancy

SPMSD Investigational Site 164, Essey-lès-Nancy

SPMSD Investigational Site 136, Floirac

SPMSD Investigational Site 114, Frouard

SPMSD Investigational Site 150, Haguenau

SPMSD Investigational Site 113, Illkirch-Graffenstaden

SPMSD Investigational Site 197, Le Havre

SPMSD Investigational Site 198, Le Havre

SPMSD Investigational Site 107, Lingolsheim

SPMSD Investigational Site 115, Louverné

SPMSD Investigational Site 140, Manduel

SPMSD Investigational Site 116, Maromme

SPMSD Investigational Site 153, Marseille

SPMSD Investigational Site 134, Montpellier

SPMSD Investigational Site 129, Nogent-sur-Marne

SPMSD Investigational Site 133, Ostwald

SPMSD Investigational Site 128, Poitiers

SPMSD Investigational Site 130, Pont-à-Mousson

SPMSD Investigational Site 151, Quimper

SPMSD Investigational Site 102, Rouen

SPMSD Investigational Site 110, Rouen

SPMSD Investigational Site 199, Rouen

SPMSD Investigational Site 152, Saint-Ouen

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01546909 - Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE | Biotech Hunter | Biotech Hunter